Bruce Jackson
Stock Analyst at Benchmark
(0.84)
# 3,806
Out of 4,884 analysts
123
Total ratings
24.58%
Success rate
-26.79%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.70 | +292.86% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.28 | +514.04% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.45 | +562.25% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.90 | +746.15% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.98 | +671.81% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $59.47 | +34.53% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.55 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $53.36 | +21.81% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.74 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $30 | $4.60 | +552.17% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.67 | +86.57% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.21 | +147.93% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.20 | +127.44% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.68 | +4,311.76% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.80 | +1,478.95% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.36 | +4,622.22% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.99 | +2,335.31% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $2.45 | -59.18% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.73 | +584.74% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.28 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.86 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.57 | +22,308.96% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.70
Upside: +292.86%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.28
Upside: +514.04%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.45
Upside: +562.25%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.90
Upside: +746.15%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.98
Upside: +671.81%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $59.47
Upside: +34.53%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.55
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $53.36
Upside: +21.81%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.74
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.60
Upside: +552.17%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.67
Upside: +86.57%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.20
Upside: +127.44%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.68
Upside: +4,311.76%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.80
Upside: +1,478.95%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.36
Upside: +4,622.22%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.99
Upside: +2,335.31%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $2.45
Upside: -59.18%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.73
Upside: +584.74%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.28
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.86
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.57
Upside: +22,308.96%